Abstract
This comprehensive report provides an in-depth analysis of the global infertility treatment market, tracking its significant expansion through 2033. The study examines diverse segments, including assisted reproductive technologies, artificial insemination, and fertility surgeries, while categorizing products by equipment, media, and consumables. By evaluating key drivers and competitive dynamics across various patient types and end-users, the research offers actionable intelligence on technological trends and regional growth opportunities to support strategic decision-making in this evolving healthcare sector.
Related Questions
USD 3,222.8 million in 2025
8.10% (2026-2033)
Summary
Market Size and Growth
The Infertility Treatment Market reached USD 3,222.8 million in 2025 and is expected to reach USD 6,009.58 million by 2033, growing at a CAGR of 8.10% during the forecast period 2026-2033.
Executive Overview
The Infertility Treatment Market emerges as a key focus in DataM Intelligence's latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Infertility Treatment Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
Market Segmentation
By Procedure
- Assisted Reproductive Technology*
- In Vitro Fertilization
- Intracytoplasmic Morphologically Selected Sperm Injection
- Gamete Donation
- Intracytoplasmic Sperm Injection
- Surrogacy
- Artificial Insemination*
- Intrauterine Insemination
- Intracervical Insemination
- Intratubal Insemination
- Fertility Surgeries*
- Laparoscopy
- Hysteroscopy
- Myomectomy
- Laparotomy
- Tubal Ligation Reversal
- Varicocelectomy
- Microsurgical Reconstruction:
- Vasovasostomy
- Vasoepididymostomy
- Other Infertility Treatment Procedures
By Product
- Equipment*
- Microscopes
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
- Sperm Separation Devices
- Media & Consumables
- Accessories
By Patient Type
- Female Infertility Treatment*
- Male Infertility Treatment
By End-User
- Fertility Centers*
- Hospitals & Surgical Clinics
- Cryobanks
- Research Institutes
Regional Analysis
- North America: U.S., Canada, Mexico
- Europe: U.K., Italy, Germany, Russia, France, Spain, The Netherlands, and Rest of Europe
- Asia-Pacific: India, Japan, China, South Korea, Australia, Indonesia, and Rest of Asia Pacific
- South America: Colombia, Brazil, Argentina, and Rest of South America
- Middle East & Africa: Saudi Arabia, U.A.E., South Africa, and Rest of Middle East & Africa
Report Scope and Coverage
This report provides comprehensive analysis including:
- Go-to-market Strategy.
- A neutral perspective on market performance.
- Development trends, competitive landscape analysis, supply side analysis, and demand side analysis.
- Year-on-year growth, competitive benchmarking, and vendor identification.
- Development status and other significant analysis.
- Customized regional/country reports as per request and country level analysis.
- Identification of potential and niche segments and regions exhibiting promising growth.
- Detailed analysis of:
- Market Size (historical and forecast)
- Total Addressable Market (TAM)
- Serviceable Available Market (SAM)
- Serviceable Obtainable Market (SOM)
- Market Growth
- Technological Trends
- Market Share
- Market Dynamics
- Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer)
Research Process
Both primary and secondary data sources have been used in the global Infertility Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including:
- Governmental regulations
- Market conditions
- Competitive levels
- Historical data
- Market situation
- Technological advancements
- Upcoming developments in related businesses
- Market volatility
- Prospects, potential barriers, and challenges
Table of Contents
1 Methodology and Scope
1.1 Research Methodology
1.2 Research Objective and Scope of the Report
2 Market Definition and Overview
3 Executive Summary
3.1 Market Snippet by Product
3.2 Market Snippet by Procedure
3.3 Market Snippet by Patient Type
3.4 Market Snippet by End-User
3.5 Market Snippet by Region
4 Market Dynamics
4.1 Market Impacting Factors
4.1.1 Drivers
- 4.1.1.1 Declining fertility rate
4.1.2 Restraints:
- 4.1.2.1 High costs associated with assisted reproductive technology
4.1.3 Opportunity
4.1.4 Impact Analysis
5 Industry Analysis
5.1 Porter's Five Forces Analysis
5.2 Supply Chain Analysis
5.3 PEST Analysis
5.4 Pricing Analysis
5.5 Regulatory Analysis
5.6 Unmet Needs
5.7 Patent Analysis
6 By Procedure
6.1 Introduction
6.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
6.1.2 Market Attractiveness Index, By Procedure
6.2 Assisted Reproductive Technology*
6.2.1 Introduction
6.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
6.2.3 In Vitro Fertilization
6.2.4 Intracytoplasmic Morphologically Selected Sperm Injection
6.2.5 Gamete Donation
6.2.6 Intracytoplasmic Sperm Injection
6.2.7 Surrogacy
6.3 Artificial Insemination
6.3.1 Intrauterine Insemination
6.3.2 Intracervical Insemination
6.3.3 Intratubal Insemination
6.4 Fertility Surgeries
6.4.1 Laparoscopy
6.4.2 Hysteroscopy
6.4.3 Myomectomy
6.4.4 Laparotomy
6.4.5 Tubal Ligation Reversal
6.4.6 Varicocelectomy
6.4.7 Microsurgical Reconstruction
- 6.4.7.1 Vasovasostomy
- 6.4.7.2 Vasoepididymostomy
6.5 Other Infertility Treatment Procedures
7 By Product
7.1 Introduction
7.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
7.1.2 Market Attractiveness Index, By Product
7.2 Equipment*
7.2.1 Introduction
7.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.2.3 Microscopes
7.2.4 Imaging Systems
7.2.5 Sperm Analyzer Systems
7.2.6 Ovum Aspiration Pumps
7.2.7 Micromanipulator Systems
7.2.8 Incubators
7.2.9 Gas Analyzers
7.2.10 Laser Systems
7.2.11 Cryosystems
7.2.12 Sperm Separation Devices
7.3 Media & Consumables
7.4 Accessories
8 By Patient Type
8.1 Introduction
8.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
8.1.2 Market Attractiveness Index, By Patient Type
8.2 Female Infertility Treatment*
8.2.1 Introduction
8.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3 Male Infertility Treatment
9 By End-User
9.1 Introduction
9.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
9.1.2 Market Attractiveness Index, By End-User Segment
9.2 Fertility Centers*
9.2.1 Introduction
9.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3 Hospitals & Surgical Clinics
9.4 Cryobanks
9.5 Research Institutes
10 By Region
10.1 Introduction
10.1.1 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
10.1.2 Market Attractiveness Index, By Region
10.2 North America
10.2.1 Introduction
10.2.2 Key Region-Specific Dynamics
10.2.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
10.2.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.2.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
10.2.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.2.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 10.2.7.1 U.S
- 10.2.7.2 Canada
- 10.2.7.3 Mexico
10.3 Europe
10.3.1 Introduction
10.3.2 Key Region-Specific Dynamics
10.3.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
10.3.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.3.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
10.3.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.3.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 10.3.7.1 Germany
- 10.3.7.2 U.K
- 10.3.7.3 France
- 10.3.7.4 Italy
- 10.3.7.5 Spain
- 10.3.7.6 Rest of Europe
10.4 South America
10.4.1 Introduction
10.4.2 Key Region-Specific Dynamics
10.4.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
10.4.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.4.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
10.4.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.4.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 10.4.7.1 Brazil
- 10.4.7.2 Argentina
- 10.4.7.3 Rest of South America
10.5 Asia Pacific
10.5.1 Introduction
10.5.2 Key Region-Specific Dynamics
10.5.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
10.5.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.5.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
10.5.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.5.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 10.5.7.1 China
- 10.5.7.2 India
- 10.5.7.3 Japan
- 10.5.7.4 Australia
- 10.5.7.5 Rest of Asia Pacific
10.6 Middle East and Africa
10.6.1 Introduction
10.6.2 Key Region-Specific Dynamics
10.6.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
10.6.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.6.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
10.6.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
11 Competitive Landscape
11.1 Competitive Scenario
11.2 Key Developments and Strategies
11.3 Company Share Analysis
11.4 Product Benchmarking
11.5 Key Companies to Watch
11.6 Company with disruptive technology
12 Global Infertility Treatments Market- Company Profiles
12.1 CooperSurgical Inc*
12.1.1 Company Overview
12.1.2 Product Portfolio and Description
12.1.3 Key Highlights
12.1.4 Financial Overview
12.2 Vitrolife
12.3 FUJIFILM Irvine Scientific, Inc
12.4 Genea Limited
12.5 IVFtech ApS
12.6 Kitazato Corporation
12.7 Rocket Medical plc
12.8 Gynemedia
12.9 Boston IVF
12.10 Aspire Fertility(*LIST NOT EXHAUSTIVE)
13 DataM Intelligence
13.1 Appendix
13.2 About Us and Services
13.3 Contact Us